Fund moves

Cencora (COR): Earnest Partners LLC reduced its stake -50K shares

Earnest Partners LLC reduced its stake in Cencora, per its Q2 2025 13F.

241K
Shares reported · -50K vs prior quarter
0.33%
Disclosed portfolio weight
$72.2M
Reported value
Holdings as of
Jun 30, 2025
Filed
Aug 15, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 12, 2025CongressDisclosed sale of COR — reported range $50,001 - $100,000
  2. Jun 18, 2025Insider · 2 peopleInsiders: 2 sales (~$2.7M)
  3. Jun 24, 2025InsiderChair sold ~$4.27M of COR shares in the open market
  4. Jul 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
  5. Jul 22, 2025InsiderChair sold ~$4.27M of COR shares in the open market
  6. Jul 29, 2025FDARecall: Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC 60687-695-01 - Carton NDC [6…

What came next

  1. Aug 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
  2. Aug 19, 2025InsiderChair sold ~$4.23M of COR shares in the open market
  3. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217…
  4. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 (10x10) blisterpacks, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. 50 Tablet…
  5. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217…
  6. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual Dose NDC: 60687-430-11); b) 100 (10x10)…
  7. Sep 5, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  8. Sep 15, 2025FDARecall: Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carto…
  9. Sep 16, 2025InsiderChair sold ~$9.09M of COR shares in the open market
  10. Sep 18, 2025InsiderCEO sold ~$1.48M of COR shares in the open market
  11. Oct 1, 2025InsiderOfficer sold ~$591K of COR shares in the open market
  12. Oct 9, 2025FDARecall: Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC […
  13. Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, carton NDC 606…
  14. Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 2 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC…
  15. Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC…
  16. Oct 20, 2025InsiderCEO sold ~$1.67M of COR shares in the open market
  17. Nov 5, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  18. Nov 18, 2025InsiderCEO sold ~$1.87M of COR shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Cencora

For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

How this filing works

Explore the data

Common questions

What does this filing report about Cencora (COR) stock?

Earnest Partners LLC reduced its stake in Cencora, per its Q2 2025 13F. Now 241K shares, $72.2M reported value, 0.33% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2025. Filed: Aug 15, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Cencora recently?

For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the COR page.

Does this mean COR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Cencora

Everything OQRO holds on this company is on its COR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data